205 related articles for article (PubMed ID: 1980182)
1. Hemodynamic effects of H2-receptor antagonists.
Iberti TJ
DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
[TBL] [Abstract][Full Text] [Related]
2. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
Moore JG
DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
[TBL] [Abstract][Full Text] [Related]
3. Overview of the safety profile of the H2-receptor antagonists.
Hansten PD
DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183
[TBL] [Abstract][Full Text] [Related]
4. Use of H2-receptor antagonists in children.
Dimand RJ
DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
[TBL] [Abstract][Full Text] [Related]
5. Histamine H2-receptor antagonists.
Keithley JK
Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
[TBL] [Abstract][Full Text] [Related]
6. Controlling gastric pH: the impact of newer agents on the critically ill patient.
Earnest DL
DICP; 1990 Nov; 24(11 Suppl):S31-4. PubMed ID: 1980181
[TBL] [Abstract][Full Text] [Related]
7. H(2) antagonist-induced thrombocytopenia: is this a real phenomenon?
Wade EE; Rebuck JA; Healey MA; Rogers FB
Intensive Care Med; 2002 Apr; 28(4):459-65. PubMed ID: 11967601
[TBL] [Abstract][Full Text] [Related]
8. Clinical review of histamine2 receptor antagonists.
Lipsy RJ; Fennerty B; Fagan TC
Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
[TBL] [Abstract][Full Text] [Related]
9. Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill.
More DG; Raper RF; Munro IA; Watson CJ; Boutagy JS; Shenfield GM
Surgery; 1985 Feb; 97(2):215-24. PubMed ID: 3881838
[TBL] [Abstract][Full Text] [Related]
10. Safety and acid-suppressant properties of histamine2-receptor antagonists for the prevention of stress-related mucosal damage in critical care patients.
Schentag JJ; Carter CA; Welage LS
DICP; 1989 Oct; 23(10 Suppl):S36-9. PubMed ID: 2573208
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
12. Safety profile of H2-receptor antagonists: current status of famotidine.
Levine JB
J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
[TBL] [Abstract][Full Text] [Related]
13. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
14. [I.v. famotidine versus i.v. ranitidine: intragastric pH behavior in surgical intensive care patients].
Friedl W; Krier C; Dammann HG; Müller P; Simon B
Z Gastroenterol; 1985 Nov; 23(11):603-7. PubMed ID: 2868579
[TBL] [Abstract][Full Text] [Related]
15. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
16. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
Miagkova LP; Grebenev AL; Kkhorshed AM
Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
[No Abstract] [Full Text] [Related]
17. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
18. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
19. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
20. Stress-related mucosal damage: review of drug therapy.
Vorder Bruegge WF; Peura DA
J Clin Gastroenterol; 1990; 12 Suppl 2():S35-40. PubMed ID: 1978844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
